Cited by 165Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsCholinesterase and Neurodegenerative Diseases

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Neuroprotective Effects of Resveratrol Against Aβ Administration in Rats are Improved by Lipid-Core Nanocapsules

Open access

Frozza, Rudimar L., Bernardi, Andressa, Hoppe, Juliana B., Meneghetti, André B., Matté, Aline, Battastini, Ana M. O., Pohlmann, Adriana R., Guterres, Sílvia S., Salbego, Christianne·2013·Molecular Neurobiology

DOI 10.1007/s12035-013-8401-2

Open this paper in CoChat — free account

Abstract

Alzheimer's disease (AD), a neurodegenerative disorder exhibiting a gradual decline in cognitive function, is characterized by the presence of neuritic plaques composed of neurofibrillary tangles and amyloid-β (Aβ) peptide. Available drugs for AD therapy have small effect sizes and do not alter disease progression. Several studies have been shown that resveratrol is associated with anti-amyloidogenic properties, but therapeutic application of its beneficial effects is limited. Here we compared the neuroprotective effects of free resveratrol treatment with those of resveratrol-loaded lipid-core nanocapsule treatment against intracerebroventricular injection of Aβ1-42 in rats. Animals received a single intracerebroventricular injection of Aβ1-42 (2 nmol), and 1 day after Aβ infusion, they were administered either free resveratrol (RSV) or resveratrol-loaded lipid-core nanocapsules (5 mg/kg, each 12 h, intraperitoneally), for 14 days. Aβ1-42-infused animals showed a significant impairment on learning memory ability, which was paralleled by a significant decrease in hippocampal synaptophysin levels. Furthermore, animals exhibited activated astrocytes and microglial cells, as well as disturbance in c-Jun N-terminal kinase (JNK) and glycogen synthase kinase-3β (GSK-3β) activation, beyond destabilization of β-catenin levels. Our results clearly show that by using lipid-core nanocapsules, resveratrol was able to rescue the deleterious effects of Aβ1-42 while treatment with RSV presented only partial beneficial effects. These findings might be explained by the robust increase of resveratrol concentration in the brain tissue achieved by lipid-core nanocapsules. Our data not only confirm the potential of resveratrol in treating AD but also offer an effective way to improve the efficiency of resveratrol through the use of nanodrug delivery systems.

Integrity signals

Registry

Crossref · 10.1007/s12035-013-8401-2

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data
Ennaceur, A., & Delacour, J. (1988) · Behavioural Brain Research · doi:10.1016/0166-4328(88)90157-x · Cited by 3,223
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Wnt signaling: a common theme in animal development
Cadigan, K. M., & Nusse, R. (1997) · Genes & Development · doi:10.1101/gad.11.24.3286 · Cited by 2,567
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Liu, C., Li, Y., Semënov, M. V., Han, C., Baeg, G., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,152

Show all 81 references

Sorted by citations

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier
Upadhyay, R. K. (2014) · BioMed Research International · doi:10.1155/2014/869269 · Cited by 544
Neuroprotective action of resveratrol
Bastianetto, S., Ménard, C., & Quirion, R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.011 · Cited by 423
Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1
Gomes, B. A. Q., Silva, J. P. B., Romeiro, C. F. R., dos Santos, S. M., Rodrigues, C. A., Gonçalves, P. R., Sakai, J. T., Mendes, P. F. S., Varela, E. L. P., & Monteiro, M. C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8152373 · Cited by 403
Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights
Coutinho, D. D. S., Pacheco, M. T., Frozza, R. L., & Bernardi, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061812 · Cited by 308
Self-citation
Polyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related Diseases
Reinisalo, M., Kårlund, A., Koskela, A. K. J., Kaarniranta, K., & Karjalainen, R. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/340520 · Cited by 299
Neuroprotective effects of resveratrol in Alzheimer disease pathology
Rege, S. D., Geetha, T., Griffin, G. D., Broderick, T. L., & Babu, J. R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00218 · Cited by 250
Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E
Neves, A. R., Queiroz, J. F., & Reis, S. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0177-x · Cited by 244
Protein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic Compounds
Stefani, M., & Rigacci, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612411 · Cited by 245
The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer’s Disease: Therapeutic Implications and Future Perspectives
Jurcău, M. C., Andronie-Cioara, F. L., Jurcău, A., Marcu, F., Ţiț, D. M., Pașcalău, N., & Nistor-Cseppentö, D. C. (2022) · Antioxidants · doi:10.3390/antiox11112167 · Cited by 226
Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: Involvement of BDNF and Akt/GSK-3β signaling pathway
Hoppe, J. B., Coradini, K., Frozza, R. L., de Oliveira, C. M., Meneghetti, A., Bernardi, A., Pires, E. N. S., Beck, R. C. R., & Salbego, C. G. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.08.001 · Cited by 209
Self-citation
Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease
Agis-Torres, A., Sollhuber, M., Fernandez, M., & Sanchez-Montero, J. M. (2014) · Current Neuropharmacology · doi:10.2174/1570159x113116660047 · Cited by 202
Co-encapsulation of resveratrol and curcumin in lipid-core nanocapsules improves their in vitro antioxidant effects
Coradini, K., Lima, F. O., Oliveira, C. M., Chaves, P. S., Athayde, M. L., Carvalho, L. M., & Beck, R. C. R. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.04.009 · Cited by 200
Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas
Zanotto‐Filho, A., Braganhol, E., Klafke, K., Figueiró, F., Terra, S. R., Paludo, F. J. D. O., Morrone, M. D. S., Bristot, I. J., Battastini, A. M. O., Forcelini, C. M., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.044 · Cited by 200
Self-citation
Role of phenolic acid, tannins, stilbenes, lignans and flavonoids in human health – a review
OLUWOLE, O. B., Fernando, W. M. A. D. B., Lumanlan, J. C., Ademuyiwa, O. H., & Jayasena, V. (2022) · International Journal of Food Science & Technology · doi:10.1111/ijfs.15936 · Cited by 201
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Moradi, S. Z., Momtaz, S., Bayrami, Z., Farzaei, M. H., & Abdollahi, M. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00238 · Cited by 187
Resveratrol and Alzheimer’s Disease: Mechanistic Insights
Ahmed, T., Javed, S., Javed, S., Tariq, A., Šamec, D., Tejada, S., Nabavi, S. F., Braidy, N., & Nabavi, S. M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9839-9 · Cited by 183
Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment
Andrade, S., Ramalho, M. J., Pereira, M. D. C., & Loureiro, J. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01261 · Cited by 173
Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression
Andronie-Cioară, F. L., Ardelean, A. I., Nistor-Cseppento, C. D., Jurcău, A., Jurcău, M. C., Pașcalău, N., & Marcu, F. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031869 · Cited by 170
Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols
Camilleri, A., Zarb, C., Caruana, M., Ostermeier, U., Ghio, S., Högen, T., Schmidt, F., Giese, A., & Vassallo, N. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.06.026 · Cited by 166
Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer’s and Parkinson’s Disease
Caruana, M., Cauchi, R. J., & Vassallo, N. (2016) · Frontiers in Nutrition · doi:10.3389/fnut.2016.00031 · Cited by 164
Phenolic Compounds Characteristic of the Mediterranean Diet in Mitigating Microglia-Mediated Neuroinflammation
Ortega, R. H., Cerezo, A. B., de Pablos, R. M., Krisa, S., Richard, T., García-Parrilla, M. C., & Troncoso, A. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00373 · Cited by 136
Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases
Marino, A., Battaglini, M., Moles, N., & Ciofani, G. (2022) · ACS Omega · doi:10.1021/acsomega.2c03291 · Cited by 137
Improved Neuroprotective Effects of Resveratrol-Loaded Polysorbate 80-Coated Poly(Lactide) Nanoparticles in MPTP-Induced Parkinsonism
Lindner, G. D. R., Santos, D. B., Colle, D., Moreira, E. L. G., Prediger, R. D., Farina, M., Khalil, N. M., & Mainardes, R. M. (2015) · Nanomedicine · doi:10.2217/nnm.14.165 · Cited by 126
Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity
Paiva‐Santos, A. C., Pereira, I., Pereira‐Silva, M., Ferreira, L., Caldas, M., Collado-González, M., Magalhães, M., Figueiras, A., Ribeiro, A. J., & Veiga, F. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.04.030 · Cited by 121
Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditions
Sandhir, R., Yadav, A., Sunkaria, A., & Singhal, N. K. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.08.011 · Cited by 123
Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson’s disease models
Ganesan, P., Ko, H.-M., Kim, I., & Choi, D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s93918 · Cited by 119
Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases
Dai, Y., Guo, Y., Tang, W., Chen, D., Xue, L., Chen, Y., Guo, Y., Wei, S., Wu, M., Dai, J., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02501-9 · Cited by 128
Natural Products as a Potential Modulator of Microglial Polarization in Neurodegenerative Diseases
Jin, X., Liu, M.-Y., Zhang, D.-F., Zhong, X., Du, K., Qian, P., Gao, H., & Wei, M.-J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104253 · Cited by 109
Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer’s disease induced by β-amyloid 1-42 peptide in aged female mice
Giacomeli, R., Izoton, J. C., dos Santos, R. B., Boeira, S. P., Jessé, C. R., & Haas, S. E. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146325 · Cited by 109
Berberine was neuroprotective against an in vitro model of brain ischemia: Survival and apoptosis pathways involved
Pires, E. N. S., Frozza, R. L., Hoppe, J. B., Menezes, B. D. M., & Salbego, C. G. (2014) · Brain Research · doi:10.1016/j.brainres.2014.02.021 · Cited by 107
Self-citation
A novel approach to arthritis treatment based on resveratrol and curcumin co-encapsulated in lipid-core nanocapsules: In vivo studies
Coradini, K., Friedrich, R. B., da Fonseca, F. N., Vencato, M., de Andrade, D. F., de Oliveira, C. M., Battistel, A. P., Guterres, S. S., da Rocha, M. I. D. U. M., Pohlmann, A. R., et al. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.07.012 · Cited by 105
Self-citation
Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins
Guerrero‐Munoz, M. J., Castillo‐Carranza, D. L., & Kayed, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.023 · Cited by 105
Oral Administration of Resveratrol-Loaded Solid Lipid Nanoparticle Improves Insulin Resistance Through Targeting Expression of SNARE Proteins in Adipose and Muscle Tissue in Rats with Type 2 Diabetes
Mohseni, R., Sadeghabadi, Z. A., Ziamajidi, N., Abbasalipourkabir, R., & Farimani, A. R. (2019) · Nanoscale Research Letters · doi:10.1186/s11671-019-3042-7 · Cited by 100
The Interaction of Polyphenols and the Gut Microbiota in Neurodegenerative Diseases
Zhang, Y., Yu, W., Zhang, L., Wang, M., & Chang, W. (2022) · Nutrients · doi:10.3390/nu14245373 · Cited by 101
Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex
Schweiger, S., Matthes, F., Posey, K. L., Kickstein, E., Weber, S. S., Hettich, M. M., Pfurtscheller, S., Ehninger, D., Schneider, R., & Krauß, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12974-4 · Cited by 92
The protective role of plant biophenols in mechanisms of Alzheimer's disease
Omar, S. H., Scott, C., Hamlin, A. S., & Obied, H. K. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.016 · Cited by 84
Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective
Ahmad, J., Akhter, S., Rizwanullah, M., Khan, M. A., Pigeon, L., Addo, R. T., Greig, N. H., Midoux, P., Pichon, C., & Kamal, M. A. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170508121031 · Cited by 81
Nanocarriers for resveratrol delivery: Impact on stability and solubility concerns
Paiva‐Santos, A. C., Pereira, I., Pereira‐Silva, M., Ferreira, L., Caldas, M., Magalhães, M., Figueiras, A., Ribeiro, A. J., & Veiga, F. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.07.048 · Cited by 79
Resveratrol: A potential therapeutic natural polyphenol for neurodegenerative diseases associated with mitochondrial dysfunction
Yadav, E., Yadav, P. S., Khan, M. M. U., Singh, H., & Verma, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.922232 · Cited by 81
Resveratrol, a natural polyphenol, prevents chemotherapy-induced cognitive impairment: Involvement of cytokine modulation and neuroprotection
Shi, D., Dong, C. M., Ho, L. C., Lam, C. T. W., Zhou, X., Wu, E. X., Zhou, Z., Wang, X., & Zhang, Z.-J. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.03.006 · Cited by 79
Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling
Han, Y., Jiang, C., Tang, J., Wang, C., Wu, P., Zhang, G., Liu, W., Jamangulova, N., Wu, X., & Song, X. (2014) · European Journal of Pain · doi:10.1002/ejp.511 · Cited by 77
Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease
Singh, S. P., Nand, S., Maurya, A., Mishra, G., Awasthi, R., Shakya, A., Chellappan, D. K., Dua, K., Vamanu, E., Chaudhary, S. K., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5578574 · Cited by 77
Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds
Ramalho, M. J., Andrade, S., Loureiro, J. A., & do Carmo Pereira, M. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00694-3 · Cited by 75
Xanthoceraside Could Ameliorate Alzheimer’s Disease Symptoms of Rats by Affecting the Gut Microbiota Composition and Modulating the Endogenous Metabolite Levels
Zhou, H., Tai, J., Xu, H., Lu, X., & Meng, D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01035 · Cited by 72
Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols
Rigacci, S., & Stefani, M. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.986101 · Cited by 69
Melatonin delivery by nanocapsules during in vitro bovine oocyte maturation decreased the reactive oxygen species of oocytes and embryos
Remião, M. H., Lucas, C. G., Domingues, W. B., da Silveira, T. L. R., Barther, N. N., Komninou, E. R., Basso, A. C., Jornada, D. S., Beck, R. C. R., Pohlmann, A. R., et al. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.05.016 · Cited by 69
Self-citation
Magnetic Resveratrol Liposomes as a New Theranostic Platform for Magnetic Resonance Imaging Guided Parkinson’s Disease Targeting Therapy
Wang, M., Li, L., Zhang, X., Liu, Y., Zhu, R., Liu, L., Fang, Y., Gao, Z., & Gao, D. (2018) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.8b04507 · Cited by 69
Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease
Lauzon, M.-A., Daviau, A., Marcos, B., & Faucheux, N. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.024 · Cited by 66
The Tragedy of Alzheimer’s Disease: Towards Better Management via Resveratrol-Loaded Oral Bilosomes
Abbas, H., Gad, H. A., Khattab, M. A., & Mansour, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101635 · Cited by 62
Effect of Resveratrol on Reactive Oxygen Species-Induced Cognitive Impairment in Rats with Angiotensin II-Induced Early Alzheimer’s Disease †
Lin, Y., Wu, Y., Sun, G., Ho, C., Wong, T., Lin, C., Chen, H., Yeh, T., Li, C., Tseng, C., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100329 · Cited by 62
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases
McCubrey, J. A., Lertpiriyapong, K., Steelman, L. S., Abrams, S. L., Cocco, L., Ratti, S., Martelli, A. M., Candido, S., Libra, M., Montalto, G., et al. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.05.005 · Cited by 60
Trans-resveratrol Inhibits Tau Phosphorylation in the Brains of Control and Cadmium Chloride-Treated Rats by Activating PP2A and PI3K/Akt Induced-Inhibition of GSK3β
Shati, A. A., & Alfaifi, M. Y. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2683-8 · Cited by 58
TRPM2 in the Brain: Role in Health and Disease
Sita, G., Hrelia, P., Graziosi, A., Ravegnini, G., & Morroni, F. (2018) · Cells · doi:10.3390/cells7070082 · Cited by 57
Genistein protects against amyloid‐beta‐induced toxicity in SH‐SY5Y cells by regulation of Akt and Tau phosphorylation
Petry, F. D. S., Coelho, B. P., Gaelzer, M. M., Kreutz, F., Guma, F. T. C. R., Salbego, C. G., & Trindade, V. M. T. (2019) · Phytotherapy Research · doi:10.1002/ptr.6560 · Cited by 57
Self-citation
Nanotechnology-based herbal medicine: Preparation, synthesis, and applications in food and medicine
Awlqadr, F. H., Majeed, K. R., Altemimi, A. B., Hassan, A. M. A., Qadir, S. A., Saeed, M. N., Faraj, A. M., Salih, T. H., Al‐Manhel, A. J. A., Najm, M. A. A., et al. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.101661 · Cited by 67
Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders
Неганова, М. Е., Aleksandrova, Y. R., Sukocheva, O. A., & Klochkov, S. G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.06.011 · Cited by 56
Resveratrol Nanoparticles: A Promising Therapeutic Advancement over Native Resveratrol
Chung, I., Subramanian, U., Thirupathi, P., Venkidasamy, B., Samynathan, R., Gangadhar, B. H., Rajakumar, G., & Thiruvengadam, M. (2020) · Processes · doi:10.3390/pr8040458 · Cited by 53
α-bisabolol-loaded lipid-core nanocapsules reduce lipopolysaccharide-induced pulmonary inflammation in mice
D’Almeida, A. P. L., de Oliveira, M. P., de Souza, É., Coutinho, D. D. S., Ciambarella, B. T., Gomes, C., Terroso, T. F., Guterres, S. S., Pohlmann, A. R., Silva, P., et al. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s130798 · Cited by 50
Self-citation
Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential
Sousa, J. C. E., SANTANA, A. C. F., & MAGALHÃES, G. J. P. (2020) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20200010 · Cited by 49
The Role of Sirtuin 1 (SIRT1) in Neurodegeneration
Razick, D., Akhtar, M., Wen, J., Alam, M., Dean, N., Karabala, M., Ansari, U., Ansari, Z., Tabaie, E. A., & Siddiqui, S. (2023) · Cureus · doi:10.7759/cureus.40463 · Cited by 48
Advances in Nanomedicine for the Treatment of Alzheimer’s and Parkinson’s Diseases
Hernando, S., Gartziandia, O., Herrán, E., Pedraz, J. L., Igartúa, M., & Hernández, R. M. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0019 · Cited by 48
Impaired autophagy: a link between neurodegenerative and neuropsychiatric diseases
Polajnar, M., & Žerovnik, E. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12349 · Cited by 49
Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases
Paramanick, D., Singh, V. D., & Singh, V. K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.058 · Cited by 47
Resveratrol Protects Hippocampal Astrocytes Against LPS-Induced Neurotoxicity Through HO-1, p38 and ERK Pathways
Bellaver, B., de Souza, D. G., Bobermin, L. D., Souza, D. O., Gonçalves, C., & Quincozes‐Santos, A. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1636-8 · Cited by 46
Chrysin loaded lipid-core nanocapsules ameliorates neurobehavioral alterations induced by β-amyloid1-42 in aged female mice
Giacomeli, R., de Gomes, M. G., Reolon, J. B., Haas, S. E., Colomé, L. M., & Jessé, C. R. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112696 · Cited by 50
Genistein attenuates amyloid-beta-induced cognitive impairment in rats by modulation of hippocampal synaptotoxicity and hyperphosphorylation of Tau
Petry, F. D. S., Hoppe, J. B., Klein, C. P., dos Santos, B. G., Hözer, R. M., Bifi, F., Matté, C., Salbego, C. G., & Trindade, V. M. T. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108525 · Cited by 46
Self-citation
Alterations on Na+,K+-ATPase and Acetylcholinesterase Activities Induced by Amyloid-β Peptide in Rat Brain and GM1 Ganglioside Neuroprotective Action
Kreutz, F., Scherer, E. B. D. S., Ferreira, A. G. K., Petry, F. D. S., Pereira, C. L., Santana, F., Wyse, Â. T. D. S., Salbego, C. G., & Trindade, V. M. T. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1145-6 · Cited by 45
Self-citation
Comparison of the Effect of Exercise on Late-Phase LTP of the Dentate Gyrus and CA1 of Alzheimer’s Disease Model
Dao, A. T., Zagaar, M. A., Levine, A. T., & Alkadhi, K. A. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9612-5 · Cited by 43
JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology
Solas, M., Vela, S., Smerdou, C., Martišová, E., Martínez-Valbuena, I., Luquín, M. R., & Ramírez, M. J. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00093 · Cited by 42
Decreased Netrin-1 and Correlated Th17/Tregs Balance Disorder in Aβ1–42 Induced Alzheimer’s Disease Model Rats
Sun, L., Ju, T., Wang, T., Zhang, L., Ding, F., Zhang, Y., An, R., Sun, Y., Li, Y., Lu, Y., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00124 · Cited by 45
Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
Varesi, A., Campagnoli, L. I. M., Carrara, A., Pola, I., Floris, E., Ricevuti, G., Chirumbolo, S., & Pascale, A. (2023) · Antioxidants · doi:10.3390/antiox12010180 · Cited by 51
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity
Severini, C., Lattanzi, R., Maftei, D., Marconi, V., Ciotti, M. T., Passeri, P. P., Florenzano, F., DUCA, E. D., Caioli, S., Zona, C., et al. (2015) · Scientific Reports · doi:10.1038/srep15301 · Cited by 40
Resveratrol-loaded nanoemulsion prevents cognitive decline after abdominal surgery in aged rats
Locatelli, F. M., Kawano, T., Iwata, H., Aoyama, B., Eguchi, S., Nishigaki, A., Yamanaka, D., Tateiwa, H., Shigematsu-Locatelli, M., & Yokoyama, M. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.08.006 · Cited by 40
The role of nutrition in space exploration: Implications for sensorimotor, cognition, behavior and the cerebral changes due to the exposure to radiation, altered gravity, and isolation/confinement hazards of spaceflight
Zwart, S. R., Mulavara, A. P., Williams, T. J., George, K. A., & Smith, S. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.026 · Cited by 45
Eicosapentaenoic Acid-Enriched Phosphatidylcholine Mitigated Aβ1-42-Induced Neurotoxicity via Autophagy-Inflammasome Pathway
Wen, M., Ding, L., Zhang, L., Zhang, T., Yanagita, T., Wang, Y., & Xue, C. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05947 · Cited by 39
Curcumin, Naringenin and Resveratrol from Natural Plant Products Hold Promising Solutions for Modern World Diseases – A Recent Review
Rathinavel, T., Bhuvaneswari, M., Haritha, S., Jeevarathna, S., Janani, K. S. S., & Suresh, K. (2022) · South African Journal of Botany · doi:10.1016/j.sajb.2022.06.027 · Cited by 42
Modulating Inflammation-Mediated Diseases via Natural Phenolic Compounds Loaded in Nanocarrier Systems
Rakotondrabe, T. F., Fan, M., Muema, F. W., & Guo, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020699 · Cited by 41
Glia and TRPM2 Channels in Plasticity of Central Nervous System and Alzheimer’s Diseases
Wang, J., Jackson, M. F., & Xie, Y. (2016) · Neural Plasticity · doi:10.1155/2016/1680905 · Cited by 35
New insights in drug development for Alzheimer's disease based on microglia function
Qiao, O., Ji, H., Zhang, Y., Zhang, X., Zhang, X., Liu, N., Huang, L., Liu, C., & Gao, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111703 · Cited by 35
Targeted Intracellular Delivery of Resveratrol to Glioblastoma Cells Using Apolipoprotein E-Containing Reconstituted HDL as a Nanovehicle
Kim, S. H., Adhikari, B. B., Cruz, S., Schramm, M. P., Vinson, J. A., & Narayanaswami, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135130 · Cited by 33
Systems‐level thinking for nanoparticle‐mediated therapeutic delivery to neurological diseases
Curtis, C., Zhang, M., Liao, R., Wood, T. R., & Nance, E. A. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1422 · Cited by 32
Evaluation of novel conjugated resveratrol polymeric nanoparticles in reduction of plasma degradation, hepatic metabolism and its augmentation of anticancer activity in vitro and in vivo
Yee, Y. J., Benson, H. A., Dass, C. R., & Chen, Y. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121499 · Cited by 32
Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease
Hernando, S., Santos‐Vizcaíno, E., Igartúa, M., & Hernández, R. M. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1898 · Cited by 32
A comparative study of eicosapentaenoic acid enriched phosphatidylcholine and ethyl ester in improving cognitive deficiency in Alzheimer's disease model rats
Wen, M., Ding, L., Zhang, L., Cong, P., Zhang, T., Xu, J., Chang, Y., Wang, Y., & Xue, C. (2018) · Food & Function · doi:10.1039/c7fo01815k · Cited by 31
Nerolidol-loaded nanospheres prevent behavioral impairment via ameliorating Na+, K+-ATPase and AChE activities as well as reducing oxidative stress in the brain of Trypanosoma evansi-infected mice
Baldissera, M. D., Souza, C. F., Grando, T. H., Moreira, K. L. S., Schafer, A. S., Cossetin, L. F., da Silva, A. P. T., da Veiga, M. L., da Rocha, M. I. D. U. M., Stefani, L. M., et al. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1313-8 · Cited by 31
Possible neuromodulating role of different grape (Vitis vinifera L.) derived polyphenols against Alzheimer’s dementia: treatment and mechanisms
Fouad, G. I., & Rizk, M. Z. (2019) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-019-0149-z · Cited by 30
Neuroprotection of resveratrol against neurotoxicity induced by methamphetamine in mouse mesencephalic dopaminergic neurons
Sun, D. I., Yue, Q., Guo, W., Li, T., Zhang, J., Li, G., Liu, Z., & Sun, J. (2015) · BioFactors · doi:10.1002/biof.1221 · Cited by 26
Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings
Delbreil, P., Rabanel, J., Banquy, X., & Brambilla, D. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114397 · Cited by 25
Agrimonia pilosa Ledeb., Cinnamomum cassia Blume, and Lonicera japonica Thunb. protect against cognitive dysfunction and energy and glucose dysregulation by reducing neuroinflammation and hippocampal insulin resistance in β-amyloid-infused rats
Park, S., Kang, S., Kim, D. S., & Moon, B. R. (2016) · Nutritional Neuroscience · doi:10.1080/1028415x.2015.1135572 · Cited by 24
Resveratrol targeting tau proteins, amyloid‐beta aggregations, and their adverse effects: An updated review
Ashrafizadeh, M., Zarrabi, A., Najafi, M., Samarghandian, S., Mohammadinejad, R., & Ahn, K. S. (2020) · Phytotherapy Research · doi:10.1002/ptr.6732 · Cited by 24
Ways to enhance the bioavailability of polyphenols in the brain: A journey through the blood-brain barrier
Zhang, Y., Lv, C., & Zhao, G. (2021) · Food Reviews International · doi:10.1080/87559129.2021.1888973 · Cited by 23
Coadministration of Resveratrol and Rice Oil Mitigates Nociception and Oxidative State in a Mouse Fibromyalgia-Like Model
Klein, C. P., Cintra, M. R., Binda, N. S., Diniz, D. M., Gomez, M. V., Souto, A. A., & de Souza, A. H. (2016) · Pain Research and Treatment · doi:10.1155/2016/3191638 · Cited by 25
Nanobiotechnology in Neurodegenerative Diseases
Jampílek, J., Kráľová, K., Novák, P., & Novák, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-30930-5_4 · Cited by 22
Pomegranate as a natural source of phenolic antioxidants: a review
de Oliveira, F. L., Arruda, T. Y. P., Lima, R. D. S., Casarotti, S. N., & Morzelle, M. C. (2020) · Journal of Food Bioactives · doi:10.31665/jfb.2020.9214 · Cited by 22
A Self-Microemulsifying Formulation of Oxyresveratrol Prevents Amyloid Beta Protein-Induced Neurodegeneration in Mice
Sangsen, Y., Sooksawate, T., Likhitwitayawuid, K., Sritularak, B., & Wiwattanapatapee, R. (2018) · Planta Medica · doi:10.1055/s-0043-125337 · Cited by 21
Food to medicine transformation of stilbenoid vesicular and lipid-based nanocarriers: Technological advances
Samie, S. M. A., & Nasr, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821222-6.00011-7 · Cited by 21
Phytonanomedicines, a state-of-the-art strategy for targeted delivery of anti-inflammatory phytochemicals: A review of improved pharmacokinetic profile and therapeutic efficacy
Hussain, Z., Thu, H. E., Khan, S., Sohail, M. F., Sarfraz, R. M., Mahmood, A., & Abourehab, M. A. S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103895 · Cited by 20
Neuroprotective Effects of Curcumin-Loaded Emulsomes in a Laser Axotomy-Induced CNS Injury Model
Yılmaz, E. N., Bay, S., Öztürk, G., & Üçışık, M. H. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s272931 · Cited by 19
Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease
Kanojia, N., Thapa, K., Kaur, G., Sharma, A., Puri, V., & Verma, N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104074 · Cited by 19

Authors: Frozza, R. L., Bernardi, A., Hoppe, J. B., Meneghetti, A. B., Matté, A., Battastini, A. M. O., Pohlmann, A. R., Guterres, S. S., & Salbego, C.
Affiliations: Universidade Federal do Rio Grande do Sul (BR)
Corresponding author: Frozza, Rudimar L.
ORCID: Frozza, Rudimar L.
Bernardi, Andressa
Hoppe, Juliana B.
Meneghetti, André B.
Matté, Aline
Battastini, Ana M. O.
Pohlmann, Adriana R.
Venue: Molecular Neurobiology
Publisher: Springer Science and Business Media LLC
Published: 2013-01-12
Volume: 47
Issue: 3
Pages: 1066-1080
ISSN: 0893-7648 (ISSN-L)
1559-1182
DOI: 10.1007/s12035-013-8401-2
OpenAlex: W2037132719
Cited by: 165
References: 81
Citations by year: 2026: 2 · 2025: 9 · 2024: 10 · 2023: 17 · 2022: 18 · 2021: 9 · 2020: 17 · 2019: 17 · 2018: 14 · 2017: 13 · 2016: 11 · 2015: 12 · 2014: 12 · 2013: 4
FWCI: 9.03
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: cc-by-nc-sa
www.springer.com/tdm (tdm)
Locations: Molecular Neurobiology (publishedVersion)
PubMed (publishedVersion)
Lume (Universidade Federal do Rio Grande do Sul) (submittedVersion, cc-by-nc-sa)
Funders: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords: resveratrol, amyloid-beta 42, Alzheimer's disease, lipid-core nanocapsules, nanoparticle drug delivery, neuroprotection, learning and memory impairment, astrocyte activation, microglial activation, JNK, GSK3β, β-catenin, intracerebroventricular administration
MeSH terms: Glycogen Synthase Kinase 3 beta, Resveratrol, Animals, Astrocytes, Enzyme Activation, Hippocampus, Injections, Intraventricular, Lipids, Male, Memory Disorders, Stilbenes, Synapses, Tissue Distribution, Signal Transduction, Amyloid beta-Peptides, Rats, Wistar, Microglia, Neuroprotective Agents, Cytoprotection, Glycogen Synthase Kinase 3, JNK Mitogen-Activated Protein Kinases, beta Catenin, Rats, Nanocapsules, Protein Stability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuroprotective Effects of Resveratrol Against Aβ Administration in Rats are Improved by Lipid-Core Nanocapsules

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks